二、抽查结果 (二)跟踪抽查情况。跟踪抽查到上次抽查不合格生产单位82家，其中有9家生产单位产品仍不合格(见附 件2)。 (一)房间空气调节器。在广东、安徽、江苏、山东、浙江、福建等10个省份27家生产单位抽查27批次产 品，抽查发现2批次产品不合格，其中，有1批次产品对触及带电部件的防护不合格、1批次产品结构不 合格、1批次产品电源连接和外部软线不合格，均为安全项目；1批次产品能效等级(全年能源消耗效率) 不合格、1批次产品噪声不合格。 市场监管总局发布17种产品质量国家监督抽查情况 中新网12月29日电 据国家市场监管总局网站消息，近期，市场监管总局组织开展房间空气调节器等17 种产品质量国家监督抽查，并将抽查情况通报如下： 一、基本情况 (一)监督抽查概况。本次共抽查17种产品1018批次，在天猫、京东、抖音、淘宝、1688、拼多多等13家 平台283家销售单位抽查297批次产品，在广东、河北、山东、四川、重庆、河南等15个省份58家销售单 位抽查59批次产品，在广东、江苏、浙江、山东、河北、江西等30个省份662家生产单位抽查662批次产 品。抽查发现82批次不合格产品(1批次汽车用制动器衬片违法违规 ...

转自：市场监管总局网站 （三）洗碗机。在天猫、京东、淘宝、快手等7个平台31家销售单位抽查33批次产品，涉及广东、浙江、山东、上海、安徽、陕西等6个省份30家生 产单位的33批次产品，抽查发现3批次产品不合格，其中，有2批次产品结构不合格、1批次产品输入功率和电流不合格，均为安全项目。 | 命 品 机构 | 国 新闻 | 园 政务 | ♡ 服务 | ⇌ 互动 | 器 专题 | | --- | --- | --- | --- | --- | --- | | 你的位置:首页 > 政务 > 政府信息公开 | | | | | | | 标 题: 2025年房间空气调节器等17种产品质量国家监督抽查情况通报 | | | | | | | 素 引 号： 11100000MB0143028R/2025-915610 | | | 主题分类:通报通告 | | | | 文 号:2025年第71期 | | | 所属机构:产品质量安全监督管理司 | | | | 成文日期:2025年12月15日 | | | 发布日期: 2025年12月29日 | | | 近期，市场监管总局组织开展房间空气调节器等17种产品质量国家监督抽查。现将抽查情况通 ...

Core Insights - The conference themed "Shan Hai Ningde, Health Full Score" aims to inject strong momentum into the regional health economy by focusing on high-quality development in the health industry [1][6] Group 1: Health Industry Development - Ningde City has a diverse ecological environment and rich natural resources, making it a prime location for developing the health industry, with a forest coverage rate of 69.98% [2] - The local government has integrated the health industry into its modern industrial system, emphasizing technological innovation, talent cultivation, and ecological collaboration [2][3] - Ningde has established a "156" development system that transforms ecological advantages into industrial strengths, aiming to enhance public health and drive economic transformation [3] Group 2: Economic Contributions - Ningde ranks fourth in the province for the number of medical institution beds per capita, with 13 institutions achieving a combination of medical care and elderly care [3] - The annual output value of 17 regulated pharmaceutical enterprises exceeds 2.5 billion yuan, with specific products like Taizishen and Huangzhizi each generating over 1.5 billion yuan [3] - The massage equipment industry in Ningde has 260 enterprises with an annual output value of 22 billion yuan, showcasing the economic potential of the health sector [3] Group 3: Strategic Initiatives - The conference highlighted the release of significant documents, including the "Blue Book on Active Health Promotion and Health Management Industry Development," which reflects Ningde's commitment to standardization and innovation in the health industry [7][9] - The integration of various sectors such as medicine, manufacturing, and tourism into a cohesive health ecosystem is a strategic focus for Ningde, aligning with the "Healthy China" initiative [10] - The conference serves as a platform for technical exchange and resource integration, promoting the standardization and project cooperation within the health industry [12]

Core Insights - The stock price of Aojiahua increased by 2.01% on November 4, reaching 7.12 CNY per share, with a total market capitalization of 4.439 billion CNY [1] - Aojiahua's main business involves the design, research and development, production, and sales of various massage devices, with a revenue composition of 72.58% from massage health products [1] Financial Performance - For the period from January to September 2025, Aojiahua achieved a revenue of 3.724 billion CNY, representing a year-on-year growth of 8.43%, and a net profit attributable to shareholders of 55.2741 million CNY, also showing an increase of 8.37% [2] - Cumulative cash dividends since Aojiahua's A-share listing amount to 1.275 billion CNY, with 436 million CNY distributed over the past three years [3] Shareholder and Market Activity - As of September 30, 2025, the number of Aojiahua's shareholders decreased by 9.49% to 34,300, while the average circulating shares per person increased by 10.48% to 12,838 shares [2] - The stock has seen a price increase of 9.20% year-to-date, with a 2.59% rise over the last five trading days [1]

Core Insights - The stock price of Aojiahua increased by 2.05% on October 28, reaching 6.98 CNY per share, with a total market capitalization of 4.352 billion CNY [1] - Aojiahua's main business involves the design, research and development, production, and sales of various massage devices, with a revenue composition of 72.58% from massage health products [1] - For the first half of 2025, Aojiahua reported a revenue of 2.327 billion CNY, a year-on-year increase of 5.65%, and a net profit of 27.0314 million CNY, up 14.01% [2] Financial Performance - As of June 30, 2025, Aojiahua had 38,000 shareholders, a decrease of 14.78% from the previous period, with an average of 11,620 circulating shares per shareholder, an increase of 17.34% [2] - Cumulative cash dividends since Aojiahua's A-share listing amount to 1.275 billion CNY, with 436 million CNY distributed over the past three years [3] Market Activity - The net inflow of main funds into Aojiahua was 3.0796 million CNY, with significant buying and selling activity observed [1] - Aojiahua is categorized under the household appliances sector, specifically in the other appliances sub-sector, and is associated with concepts such as new retail and cross-border e-commerce [1]

Group 1 - The core viewpoint of the news is that Rongtai Health has seen a significant increase in its stock price, rising by 5.08% to reach 39.72 CNY per share, with a trading volume of 642 million CNY and a turnover rate of 8.80%, resulting in a total market capitalization of 7.627 billion CNY [1] - Rongtai Health, established on November 15, 2002, and listed on January 11, 2017, specializes in the design, research and development, production, and sales of massage equipment [1] Group 2 - Among the top circulating shareholders of Rongtai Health, a fund under the Fortune Fund ranks as a significant stakeholder, with the Fortune Emerging Industries Stock A/B fund newly entering the top ten circulating shareholders, holding 2.5575 million shares, which accounts for 1.44% of the circulating shares [2] - The Fortune Emerging Industries Stock A/B fund, established on March 12, 2015, has a latest scale of 3.137 billion CNY and has achieved a year-to-date return of 65.86%, ranking 134 out of 4222 in its category [2] - The fund manager, Sun Quan, has a cumulative tenure of 3 years and 188 days, with the fund's total asset size at 7.75 billion CNY, achieving a best return of 106.08% and a worst return of 38.87% during his tenure [2]

Group 1 - The core point of the news is that Rongtai Health experienced a decline of 5.34% in its stock price, reaching 35.29 CNY per share, with a trading volume of 264 million CNY and a turnover rate of 3.79%, resulting in a total market capitalization of 6.777 billion CNY [1] - Rongtai Health, established on November 15, 2002, and listed on January 11, 2017, is primarily engaged in the design, research and development, production, and sales of massage equipment [1] Group 2 - Among the top ten circulating shareholders of Rongtai Health, a fund under the Fortune Fund ranks as a significant shareholder, with the Fortune Emerging Industries Stock A/B (001048) newly entering the top ten in the second quarter, holding 2.5575 million shares, which accounts for 1.44% of the circulating shares [2] - The Fortune Emerging Industries Stock A/B (001048) was established on March 12, 2015, with a latest scale of 3.137 billion CNY. It has achieved a year-to-date return of 48.54%, ranking 189 out of 4222 in its category, and a one-year return of 120.88%, ranking 65 out of 3776 [2] Group 3 - The fund manager of Fortune Emerging Industries Stock A/B (001048) is Sun Quan, who has been in the position for 3 years and 183 days. The total asset scale of the fund is 7.75 billion CNY, with the best fund return during his tenure being 84.61% and the worst being 31.73% [3]

Core Insights - The total import and export trade volume of China's medical devices in the first half of 2025 was $38.256 billion, remaining stable compared to the same period last year, with exports at $21.794 billion, up 4.78%, and imports at $16.462 billion, down 5.87% [1] Export Performance - Exports to the United States decreased by 6.34% year-on-year, primarily affecting non-essential products like massage and health care devices, while demand for medical institution products remained stable [2] - Exports to "Belt and Road" countries grew significantly, with a year-on-year increase of 9.35%, totaling $8.286 billion, accounting for 38% of total exports [2] - The top export markets included the United States ($4.771 billion, -6.34%), Japan ($1.311 billion, +2.63%), and Germany ($1.297 billion, +11.72%) [3] Product Export Breakdown - The leading exported product was massage devices, totaling $2.114 billion, down 6.45%, while other medical and surgical instruments saw a 15.32% increase [4] - Other notable exports included catheters and similar products ($1.207 billion, +10.94%) and diagnostic reagents ($0.842 billion, +6.73%) [4] Import Performance - The total import value of medical devices was $16.462 billion, with the United States, Germany, and Japan being the primary sources, despite significant declines in imports from these countries [6][7] - Mexico showed a notable increase in exports to China, up 12.78% to $1.276 billion, as some U.S. products produced in Mexico avoided tariff impacts [6] International Cooperation and Events - The association organized a delegation to Morocco to explore international markets and strengthen cooperation in the medical field [9] - The first China Medical Equipment International Cooperation Conference was successfully held, attracting representatives from 17 countries and regions [10] - A training session for medical device operation and maintenance was conducted for officials from eight Belt and Road countries, promoting international exchange and cooperation [11] Regulatory Changes and Opportunities - Recent regulatory changes in various countries present both challenges and opportunities for Chinese medical device exports, with Malaysia initiating a mutual recognition plan for medical device regulation [16][17] - The internationalization of Chinese medical devices is accelerating, with a focus on high-value consumables and high-end medical equipment, enhancing competitiveness in global markets [18]

Investment Rating - The report rates the stock of Beilingsong as "Accumulate" with projected EPS of 0.12 in 2024 and increasing to 0.93 by 2027, indicating a significant growth potential [5]. Core Insights - The service retail sector in China is poised for substantial growth, with a market size reaching 7 trillion yuan, driven by digitalization and changing consumer preferences [21][26]. - The report emphasizes the necessity for offline retail to adapt to the challenges posed by e-commerce, highlighting the importance of unique value propositions and customer experiences [27][32]. - Successful new consumption models must focus on high customer unit prices and integrate products with services to enhance consumer engagement and brand loyalty [2][3]. Summary by Sections Service Retail: A Trillion-Yuan Blue Ocean - China's service retail development level is relatively low, with a GDP contribution of only 56.7% in 2024, compared to 60%-80% in developed countries [10][13]. - The per capita service consumption expenditure in China is projected to reach 46.1% of total consumption in 2024, indicating significant room for growth [10][21]. - The rise of digital platforms has transformed consumer experiences, leading to an exponential increase in service retail market size [25][26]. Offline Retail: Challenges and Breakthroughs - Offline retail faces significant challenges due to e-commerce competition, leading to high fixed costs and product homogenization [27][32]. - Retail models that can achieve high gross margins and customer loyalty are more likely to succeed in the current market [33][36]. New Players in Service Retail - New retail players are emerging by focusing on niche markets and addressing unmet consumer needs, such as the rise of beauty and wellness services [38][39]. - Companies like Xila and Beilingsong are leveraging standardized service models and clear franchise systems to facilitate rapid expansion [46][49]. Key Company Analysis - Beilingsong is transitioning its business model to include both technology products and quick-effect massage services, aiming to enhance customer experience and brand loyalty [4]. - Xila is expanding into scalp care, leveraging its strong brand and supply chain capabilities to become a preferred service provider for families [4].

Group 1 - The "Foreign Trade Quality Products China Tour" textile and clothing matching event was launched in Xiamen to promote high-quality foreign trade products into the domestic market, leveraging Fujian's textile and clothing industry foundation [1] - The Ministry of Commerce emphasized Fujian's role as a major foreign trade province, focusing on the transition of foreign trade enterprises to domestic sales and promoting the integration of internal and external trade standards [1] - Fujian has been actively promoting foreign trade quality products to expand into the domestic market, with various stakeholders collaborating to facilitate the transition of export goods to domestic sales [1] Group 2 - The Fujian Provincial Wholesale and Retail Industry Association issued an initiative to support foreign trade products in expanding into the domestic consumer market, establishing a "green channel" for foreign trade enterprises [2] - Retail enterprises like Yonghui Supermarket have opened a "green channel" for foreign trade suppliers, offering rapid product listing and promotional support to alleviate inventory issues caused by export disruptions [2] - Fujian Glory Health Technology Co., Ltd., a major massage equipment manufacturer, is adjusting its market strategy to focus on expanding its domestic market presence amid international uncertainties [2]